Trial: Tracerx

BTOG 2024 highlights: MARS 2 trial on mesothelioma surgery and TRACERx on lung cancer evolution

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx) (TRACERx)

Investigating tumor heterogeneity in the TRACERx study

Dr Mariam Jamal-Hanjani - The lung TRACERx study

Surrey Cancer Research Institute

PEACE and TRACERx: dissecting metastases and intra-tumor heterogeneity

Oncotype DX Testing and the TAILORx Trial

Biomarkers in Kidney Cancer: How Patients Contribute to Progress with TracerX and PEACE Trials

Early Stage Breast Cancer: TAILORx Trial

Charles Swanton - Cancer Chromosomal Evolution in Metastases & Immune Escape: Insights from TRACERx

From patient to paper: how tumour donations help Crick scientists understand cancer

Francis Crick Institute

What is the TAILORX Clinical Trial?

Breast Cancer Answers®

Harnessing lung cancer evolution for clinical benefit

UCL Faculty of Medical Sciences

Air pollution and EGFRm lung cancer: pathway identified

The ExteNET Trial

Dr. Kwa on the TAILORx Trial in Breast Cancer

Groundbreaking TAILORx trial results on women with Breast Cancer

Medical Dialogues

Ultra-sensitive and specific ctDNA assay for early stage lung cancer

the Scottish Breast Conservation Trial

The Oncology Post

Biopsy analyses from the TALAVE trial of induction talazoparib

Mechanism of action for air pollution-induced NSCLC